Queseria Arce
FDA import alert and refusal historyOaxaca de Juarez, MexicoFEI 3003446662
As of October 25, 2026, Queseria Arce (Oaxaca de Juarez, Mexico) is on the red list of FDA Import Alert 12-10 (Cheese: microbiological contamination) for asadero style mexican soft cheese, published by FDA on September 18, 2009, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 12-10 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Queseria Arce
1 record, newest first. Each line links to the FDA page it came from.
2009
- Import alert listingListed on Import Alert 12-10red listAsadero Style Mexican Soft CheeseSource
Questions about Queseria Arce
- Is Queseria Arce on an FDA import alert?
- Yes. As of October 25, 2026, Queseria Arce is on the red list of FDA Import Alert 12-10, “Cheese: microbiological contamination”, for asadero style mexican soft cheese; FDA published the listing on September 18, 2009.
- Has FDA refused shipments from Queseria Arce?
- No FDA import refusals for Queseria Arce appear in FDA's refusal data since October 2016, as of October 25, 2026.
- What is Queseria Arce's FEI number?
- Queseria Arce's FDA Establishment Identifier (FEI) is 3003446662.
- Can shipments from Queseria Arce still enter the U.S.?
- Shipments of asadero style mexican soft cheese from Queseria Arce can be detained without physical examination under Import Alert 12-10; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Queseria Arce?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.